Alvotech Sees Minimal Impact On 2025 Revenues From U.S. Tariffs

May 7 (Reuters) - Alvotech SA ALVO.O:

• POTENTIAL U.S. TARIFFS ON PHARMACEUTICALS EXPECTED TO HAVE MINIMAL IMPACT ON ALVOTECH'S PRODUCT REVENUES IN 2025

• ALVOTECH MANUFACTURES ITS BIOSIMILARS IN ICELAND, A COUNTRY WHICH CURRENTLY FACES MINIMUM TARIFF OF 10% ON GOODS IMPORTED TO U.S

• A 10% TARIFF ON PHARMACEUTICALS WOULD RAISE COST OF BIOSIMILARS FROM ALVOTECH IMPORTED TO U.S. FOR CUSTOMERS BY LESS THAN 1% OF ALVOTECH'S EXPECTED TOTAL PRODUCT REVENUES IN 2025